WealthPlan Investment Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

WealthPlan Investment Management’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$3K	Buy	+48	New	+$7.01K	﹤0.01%	382

Other funds holding AMPE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WealthPlan Investment Management's AMPE Position: Q1 2022 in Review

WealthPlan Investment Management opened a new position in Ampio Pharmaceuticals Inc. (AMPE) in Q1 2022: 48 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #382 among its holdings.

128 funds tracked by Wall St. Rank hold AMPE as of Q1 2022.

WealthPlan Investment Management held 48 shares of Ampio Pharmaceuticals Inc. worth $3K as of Q1 2022.
Ampio Pharmaceuticals Inc. was a new WealthPlan Investment Management position in Q1 2022.
Ampio Pharmaceuticals Inc. made up ﹤0.01% of WealthPlan Investment Management's portfolio in Q1 2022, its #382 holding.
128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2022.

Based on WealthPlan Investment Management's 13F filing for Q1 2022, filed 7 Sep 2022.